Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 3
1988 1
1989 6
1990 8
1991 5
1992 8
1993 8
1994 4
1995 6
1996 2
1997 1
1998 6
1999 5
2000 7
2001 10
2002 4
2003 9
2004 14
2005 17
2006 18
2007 32
2008 33
2009 32
2010 26
2011 22
2012 18
2013 30
2014 25
2015 31
2016 25
2017 16
2018 17
2019 6
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

424 results
Results by year
Filters applied: . Clear all
Page 1
Epidemiology and natural history of inflammatory bowel diseases.
Cosnes J, et al. Gastroenterology 2011. PMID 21530745
In the West, the incidence and prevalence of inflammatory bowel diseases has increased in the past 50 years, up to 8-14/100,000 and 120-200/100,000 persons, respectively, for ulcerative colitis (UC) and 6-15/100,000 and 50-200/100,000 persons, respectively, for Crohn's disease (CD). ...It has been proposed that only aggressive therapeutic approaches, based on treatment of early recurrent lesions in asymptomatic individuals, have a significant impact on progression of these chronic diseases....
In the West, the incidence and prevalence of inflammatory bowel diseases has increased in the past 50 years, up to 8-14 …
Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping.
Kakuta Y, et al. J Gastroenterol 2018 - Review. PMID 29192347 Free PMC article.
The thiopurine drugs 6-mercaptopurine (6-MP) and azathiopurine (AZA) are widely used to treat inflammatory bowel disease. However, the incidence of adverse reactions is high, particularly in Asia, and the mechanisms of toxicity in Asian populations remain unclear. ...
The thiopurine drugs 6-mercaptopurine (6-MP) and azathiopurine (AZA) are widely used to treat inflammatory bowel disease. Howe …
Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing?
Gismera CS and Aladrén BS. World J Gastroenterol 2008 - Review. PMID 18810764 Free PMC article.
Inflammatory bowel diseases (IBD) are a heterogeneous group of diseases, not always easy to diagnose, even more difficult to classify, and diagnostic criteria are not always uniform. ...
Inflammatory bowel diseases (IBD) are a heterogeneous group of diseases, not always easy to diagnose, even more
Immunochip Meta-Analysis of Inflammatory Bowel Disease Identifies Three Novel Loci and Four Novel Associations in Previously Reported Loci.
Hong M, et al. J Crohns Colitis 2018 - Review. PMID 29584801 Free PMC article.
BACKGROUND AND AIMS: Recent meta-analysis of genome-wide association studies have identified over 241 inflammatory bowel disease susceptibility loci. However, the known variants only account for a fraction of inflammatory bowel disease heritability. To identify additional susceptibility loci, we performed a trans-ethnic meta-analysis as well as an Asian-specific meta-analysis, using all published Immunochip association results of inflammatory bowel disease. ...
BACKGROUND AND AIMS: Recent meta-analysis of genome-wide association studies have identified over 241 inflammatory bowel disea …
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.
Loftus EV. Gastroenterology 2004. PMID 15168363
As many as 1.4 million persons in the United States and 2.2 million persons in Europe suffer from these diseases. Previously noted racial and ethnic differences seem to be narrowing. ...Whether other factors such as diet, oral contraceptives, perinatal/childhood infections, or atypical mycobacterial infections play a role in expression of inflammatory bowel disease remains unclear. ...
As many as 1.4 million persons in the United States and 2.2 million persons in Europe suffer from these diseases. Previously noted ra …
Genetics of inflammatory bowel diseases: a comparison between Western and Eastern perspectives.
Cheon JH. J Gastroenterol Hepatol 2013 - Review. PMID 23189979
Inflammatory bowel disease (IBD) is a chronic relapsing intestinal inflammatory disorder with unidentified causes. Currently, studies indicate that IBD results from a complex interplay between various genetic and environmental factors that produce intestinal inflammation. ...
Inflammatory bowel disease (IBD) is a chronic relapsing intestinal inflammatory disorder with unidentified causes. Curr
Association between Toll-Like Receptor 9-1237T/C Polymorphism and the Susceptibility of Inflammatory Bowel Diseases: A Meta-Analysis.
Shang J, et al. Yonsei Med J 2016. PMID 26632396 Free PMC article.
PURPOSE: The -1237T/C polymorphism of the Toll-like receptor 9 (TLR9) gene has been implicated in the susceptibility of inflammatory bowel diseases (IBDs), but the results remain conflicting. ...
PURPOSE: The -1237T/C polymorphism of the Toll-like receptor 9 (TLR9) gene has been implicated in the susceptibility of inflammatory
Racial disparities in surgical outcomes of patients with Inflammatory Bowel Disease.
Montgomery SR, et al. Am J Surg 2018 - Clinical Trial. PMID 29803499
BACKGROUND: Inflammatory Bowel Disease (IBD) has not historically been a focus of racial health disparities research. IBD has been increasing in the black community. ...
BACKGROUND: Inflammatory Bowel Disease (IBD) has not historically been a focus of racial health disparities research. IBD has …
A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population.
Schiff ER, et al. Dig Dis Sci 2018. PMID 30178286 Free PMC article.
BACKGROUND AND AIMS: The inflammatory bowel diseases (IBD) are particularly common among the Ashkenazi Jewish (AJ) population. ...
BACKGROUND AND AIMS: The inflammatory bowel diseases (IBD) are particularly common among the Ashkenazi Jewish (AJ) popu …
424 results
Jump to page
Feedback